Zydus Lifesciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NSEI:ZYDUSLIFE Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
28 Mar 24	Sell₹40,385,335	Pankaj Patel	Individual	40,000	₹1,010.62
28 Mar 24	Sell₹293,939	Deval Shah	Individual	292	₹1,006.64
27 Mar 24	Sell₹588,165,175	Pankaj Patel	Individual	583,000	₹1,015.35
26 Mar 24	Sell₹1,009,074	Harsha Gor	Individual	1,000	₹1,009.07
26 Mar 24	Sell₹643,042	Deval Shah	Individual	650	₹1,010.92
20 Mar 24	Sell₹832,676	Vishal Gor	Individual	862	₹965.98

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ZYDUSLIFE?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	17,730	0.00176%
State or Government	1,701,983	0.169%
General Public	107,347,106	10.7%
Institutions	141,718,807	14.1%
Individual Insiders	755,448,364	75.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 87.69% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
75%	Pankaj Patel	754,431,544	₹734.3b	0%	no data
3.09%	Life Insurance Corporation of India, Asset Management Arm	31,095,869	₹30.3b	-20.5%	0.21%
1.5%	Kotak Mahindra Asset Management Company Limited	15,110,091	₹14.7b	-12.1%	0.5%
1.4%	ICICI Prudential Asset Management Company Limited	14,077,632	₹13.7b	11.3%	0.24%
0.86%	BlackRock, Inc.	8,657,468	₹8.4b	-1.18%	no data
0.76%	PPFAS Asset Management Private Limited	7,678,847	₹7.5b	0%	1.0%
0.52%	BNP Paribas Arbitrage Sa, Asset Management Arm	5,235,345	₹5.1b	0%	0.05%
0.46%	Nippon Life India Asset Management Limited	4,589,838	₹4.5b	0.05%	0.11%
0.43%	Norges Bank Investment Management	4,345,059	₹4.2b	0%	no data
0.42%	Hdfc Standard Life Insurance Company Limited, Asset Management Arm	4,260,817	₹4.1b	0%	0.56%
0.37%	Axis Asset Management Company Limited	3,769,836	₹3.7b	-14.3%	0.17%
0.35%	The Vanguard Group, Inc.	3,481,108	₹3.4b	0%	no data
0.33%	UTI Asset Management Company Limited	3,338,209	₹3.2b	0.81%	0.12%
0.25%	Sundaram Asset Management Company Ltd.	2,523,447	₹2.5b	1.34%	0.49%
0.25%	Dimensional Fund Advisors LP	2,501,798	₹2.4b	1.9%	no data
0.22%	Goldman Sachs Asset Management, L.P.	2,220,411	₹2.2b	1.03%	0.01%
0.21%	quant Money Managers Ltd.	2,146,000	₹2.1b	0%	0.21%
0.2%	Desons Holdings And Finance Pvt Limited, Asset Management Arm	1,982,980	₹1.9b	0%	no data
0.18%	Mirae Asset Global Investments Co., Ltd.	1,761,104	₹1.7b	0.01%	0.02%
0.17%	Investor Education and Protection Fund (IEPF)	1,701,383	₹1.7b	-0.23%	no data
0.16%	HSBC Global Asset Management (UK) Limited	1,593,588	₹1.6b	-10.9%	0.01%
0.15%	HDFC Asset Management Company Limited	1,531,234	₹1.5b	13.5%	0.03%
0.15%	HSBC Global Asset Management (Hong Kong) Limited	1,500,000	₹1.5b	0%	0.4%
0.15%	PGIM India Asset Management Private Limited	1,493,315	₹1.5b	0%	0.51%
0.13%	Tata Asset Management Limited	1,343,994	₹1.3b	18.6%	0.12%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 11:31
End of Day Share Price	2024/12/24 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zydus Lifesciences Limited is covered by 68 analysts. 32 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Nitin Bhasin	Ambit Capital
null null	Anand Rathi Shares and Stock Brokers Limited
Sriraam Rathi	Anand Rathi Shares and Stock Brokers Limited